Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: A real-world analysis

Authors

Narendranath Epperla, The Ohio State University
Qiuhong Zhao, The Ohio State University
Tamara Moyo, Atrium Health
Marcus P Watkins, Washington University School of Medicine in St. Louis
Montreh Tavakkoli, University of Pennsylvania
Celeste Bello, H. Lee Moffitt Cancer Center and Research Institute
Pallawi Torka, Roswell Park Cancer Institute
Nishitha Reddy, Vanderbilt University
Colin Thomas, Thomas Jefferson University
Kaitlin Annunzio, The Ohio State University
Beth Christian, The Ohio State University
Stefan K Barta, University of Pennsylvania
Geoffrey Shouse, City of Hope National Medical Center
Adam J Olszewski, Brown University
Nancy L Bartlett, Washington University School of Medicine in St. Louis

Journal

Blood Advances

Publication Date

2-13-2024

Volume

8

Issue

3

First Page

549

Last Page

552

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2023011698

Rights and Permissions

Epperla N, Zhao Q, Moyo T, Watkins MP, Tavakkoli M, Bello C, Torka P, Reddy N, Thomas C, Annunzio K, Christian B, Barta SK, Shouse G, Olszewski AJ, Bartlett NL. Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis. Blood Adv. 2024 Feb 13;8(3):549-552. doi: 10.1182/bloodadvances.2023011698. © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Epperla, Narendranath; Zhao, Qiuhong; Moyo, Tamara; Watkins, Marcus P; Tavakkoli, Montreh; Bello, Celeste; Torka, Pallawi; Reddy, Nishitha; Thomas, Colin; Annunzio, Kaitlin; Christian, Beth; Barta, Stefan K; Shouse, Geoffrey; Olszewski, Adam J; and Bartlett, Nancy L, "Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: A real-world analysis." Blood Advances. 8, 3. 549 - 552. (2024).
https://digitalcommons.wustl.edu/oa_4/3413

Additional Links

Supplemental material is available for this article at publisher site.